Medtech startup Innovodigm raises Rs 5.5 crore in a seed funding round led by the Indian Angel Network and PadUp Ventures.
Funds will support process optimization, infrastructure scale-up, and team expansion for third-party preclinical validation and clinical trials.
Innovodigm develops a proprietary Microneedle Array Patch (MAP) platform for needle-free vaccine delivery with thermostable vaccines, reducing cold-chain requirements and medical waste.
Innovodigm plans to localize production with decentralized manufacturing hubs to address distribution bottlenecks in low- and middle-income countries.